Table 3 Main regression models for all comers: cross-sectional associations between APOE e4 status and Moray House Test (MHT) scores at each age separately.

From: Effect sizes of APOE e4 on the same general cognitive ability test taken by the same people from age 11 to age 90: The Lothian Birth Cohorts 1921 and 1936

  

Lothian Birth Cohort 1936 (N = 1010 at baseline age 70)

  

Model 1 – age + sex

 

Model 2 – age + sex + health covariates

MHT

N

Std est

SE

P value

95% CI

N

Std est

SE

P value

95% CI

Age 11

954

0.005

0.032

0.884

−0.058, 0.067

 

Age 70

a1001

−0.022

0.031

0.483

−0.083, 0.039

1001

−0.025

0.031

0.415

−0.086, 0.036

Age 76

636

−0.132

0.038

0.001

−0.207, −0.056

634

−0.132

0.038

0.001

−0.208, −0.057

Age 79

471

−0.161

0.044

<0.001

−0.248, −0.074

468

−0.157*

0.044

<0.001

−0.244, −0.070

  

Lothian Birth Cohort 1921 (N = 539 at baseline age 79)

Age 11

483

−0.046

0.044

0.302

−0.153, 0.041

 

Age 79

b533

−0.114

0.043

0.008

−0.197, −0.030

525

−0.112*

0.043

0.009

−0.196, −0.029

Age 87

198

−0.224

0.070

0.001

−0.362, −0.086

196

−0.231

0.069

0.001

−0.367, −0.095

Age 90

120

−0.296

0.088

0.001

−0.469, −0.123

120

−0.333

0.086

<0.001

−0.502, −0.165

  1. *The meta-analytic effect size across both cohorts at age 79 (adjusted model 2—see asterisked values above) is −0.134; SE = 0.031; P < 0.0001; 95%CI = −0.194, −0.074.
  2. aIn the LBC1936, N = 9 were missing a MHT score at older-age baseline age 70.
  3. bIn the LBC1921, N = 6 were missing an MHT score at older-age baseline age 79. The health covariates (yes/no) in model 2 are CVD, diabetes, stroke, and hypertension.
  4. P values <0.05 are indicated in bold.